AAFA Elevates Patient Voice in ICER Review of New Peanut Allergy Treatments

On June 11, 2019, in Oakland, California, the Institute for Clinical and Economic Review (ICER) and its California Technology Assessment Forum (CTAF) met to assess the clinical effectiveness and value of treatments for peanut allergy. The review examined two new technologies to induce immune tolerance — Viaskin® Peanut (DBV Technologies) and AR101 (Aimmune Therapeutics) — […]

…/Auszug

More Than 26 Million Americans Have Asthma

Asthma and allergies affect more than 60 million Americans. Allergic disease, which includes asthma, is the fifth leading chronic disease in the U.S. They can impact you socially, emotionally and financially. But asthma and allergies don’t have to define you. But working with your doctor and following your treatment plan, you can thrive and do […]

…/Auszug